Literature DB >> 7560352

Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions.

M Takahashi1, M Ito, F Sakamoto, N Shimizu, T Furukawa, M Takahashi1, Y Matsunaga.   

Abstract

Erythema infectiosum is known to be caused by human parvovirus B19 and shows characteristic clinical skin manifestations in children, although adult cases of human parvovirus B19 infection do not always show such characteristic features. Recently, we experienced an epidemic adult cases of human parvovirus B19 infection and examined the erythematous skin lesion by immunohistochemistry and electron microscopy to clarify the pathogenesis of the skin manifestations. Light microscopic examination showed slightly irregular-shaped vessels in the dermis. By immunohistochemistry, using anti-human parvovirus B19 monoclonal antibody, positive reactions were found in endothelial cells. No immunoglobulins were found, but C3 deposits were present in the perivascular areas. By electron microscopy, virus particles were found in the cytoplasm of endothelial cells. An inflammatory reaction due to the direct human parvovirus B19 infection in dermal vessels seems to be an important factor in the pathogenesis of the skin manifestations.

Entities:  

Mesh:

Year:  1995        PMID: 7560352     DOI: 10.1111/j.1600-0560.1995.tb01402.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  A One-Year-Old Girl With Human Parvovirus B19 Infection and Hypocomplementemia Mimicking Incomplete Kawasaki Disease.

Authors:  Kazumi Oura; Shinichi Ishikawa; Haruki Shiraishi; Yuji Maruo; Norio Sato; Takashi Suganuma; Makoto Mikawa; Tomonobu Sato
Journal:  J Med Cases       Date:  2022-04-23

Review 2.  Viral infection and atherosclerosis.

Authors:  Nima Hemmat; Amin Ebadi; Reza Badalzadeh; Mohammad Yousef Memar; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.